|
1.
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2.
|
Zhang S, Cui Y, Weng Z, Gong X, Chen M and
Zhong B: Changes on the disease pattern of primary colorectal
cancers in Southern China: a retrospective study of 20 years. Int J
Colorectal Dis. 24:943–949. 2009.PubMed/NCBI
|
|
3.
|
Jiang SX, Wang XS, Geng CH and Wang GY:
Altering trend of clinical characteristics of colorectal cancer: a
report of 3,607 cases. Ai Zheng. 28:54–56. 2009.PubMed/NCBI
|
|
4.
|
Suttie SA, Shaikh I, Mullen R, Amin AI,
Daniel T and Yalamarthi S: Outcome of right- and left-sided colonic
and rectal cancer following surgical resection. Colorectal Dis.
13:884–889. 2011. View Article : Google Scholar
|
|
5.
|
Bufill JA: Colorectal cancer: evidence for
distinct genetic categories based on proximal or distal tumor
location. Ann Intern Med. 113:779–788. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Elnatan J, Goh HS and Smith DR: C-KI-RAS
activation and the biological behaviour of proximal and distal
colonic adenocarcinomas. Eur J Cancer. 32A:491–497. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Bell SM, Scott N, Cross D, et al:
Prognostic value of p53 over-expression and c-Ki-ras gene mutations
in colorectal cancer. Gastroenterology. 104:57–64. 1993.PubMed/NCBI
|
|
8.
|
Breivik J, Meling GI, Spurkland A, Rognum
TO and Gaudernack G: K-ras mutation in colorectal cancer: relations
to patient age, sex and tumour location. Br J Cancer. 69:367–371.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Thibodeau SN, Bren G and Schaid D:
Microsatellite instability in cancer of the proximal colon.
Science. 260:816–819. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Christodoulidis G, Spyridakis M,
Symeonidis D, Kapatou K and Manolakis A: Clinicopathological
differences between right- and left-sided colonic tumors and impact
upon survival. Tech Coloproctol. 14(Suppl 1): S45–S47. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wray CM, Ziogas A, Hinojosa MW, Le H,
Stamos MJ and Zell JA: Tumor subsite location within the colon is
prognostic for survival after colon cancer diagnosis. Dis Colon
Rectum. 52:1359–1366. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Benedix F, Kube R, Meyer F, Schmidt U,
Gastinger I and Lippert H; Colon/Rectum Carcinomas (Primary Tumor)
Study Group: Comparison of 17,641 patients with right- and
left-sided colon cancer: differences in epidemiology, perioperative
course, histology, and survival. Dis Colon Rectum. 53:57–64. 2010.
View Article : Google Scholar
|
|
13.
|
Papagiorgis P, Oikonomakis I,
Karapanagiotou I, Wexner SD and Nikiteas N: The impact of tumor
location on the histopathologic expression of colorectal cancer. J
BUON. 11:317–321. 2006.PubMed/NCBI
|
|
14.
|
Yang YH, Dudoit S, Luu P, Lin DM, Peng V,
Ngai J and Speed TP: Normalization for cDNA microarray data: a
robust composite method addressing single and multiple slide
systematic variation. Nucl Acids Res. 30:e152002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Koo CL, Kok LF, Lee MY, et al: Scoring
mechanisms of p16INK4a immunohistochemistry based on either
independent nucleic stain or mixed cytoplasmic with nucleic
expression can significantly signal to distinguish between
endocervical and endometrial adenocarcinomas in a tissue microarray
study. J Transl Med. 7:252009.
|
|
16.
|
Li Y, Basang Z, Ding H, et al: Latexin
expression is down-regulated in human gastric carcinomas and
exhibits tumor suppressor potential. BMC Cancer. 11:1212011.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Roh SS, Lee MH, Hwang YL, et al:
Stimulation of the extra-cellular matrix production in dermal
fibroblasts by velvet antler extract. Ann Dermatol. 22:173–179.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Griffini P, Freitas I, Vigorelli E and Van
Noorden CJ: Changes in the zonation of lactate activity in lobules
of rat liver after experimentally induced colon carcinoma
metastases. Anticancer Res. 14:2537–2540. 1994.PubMed/NCBI
|
|
19.
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Yan DW, Li DW, Yang YX, et al: Ubiquitin D
is correlated with colon cancer progression and predicts recurrence
for stage II–III disease after curative surgery. Br J Cancer.
103:961–969. 2010.PubMed/NCBI
|
|
21.
|
O’Donovan N, Fischer A, Abdo EM, et al:
Differential expression of IgG Fc binding protein (FcgammaBP) in
human normal thyroid tissue, thyroid adenomas and thyroid
carcinomas. J Endocrinol. 174:517–524. 2002.PubMed/NCBI
|
